Anna Germanová - Gynecology

Author Information

Anna Germanová is affiliated with the Department of Obstetrics and Gynecology, Gynecologic Oncology Center, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, located in Prague, Czech Republic. Her research primarily focuses on gynecologic oncology, particularly involving cervical cancer.

Research Contributions

Anna Germanová has made significant contributions to the field of gynecological oncology. Her research extensively covers various aspects of cervical cancer, including surgical outcomes, prognostic markers, and diagnostic methodologies. Notably, her work on sentinel lymph node biopsy and its implications in early-stage cervical cancer has been influential. She has also explored the prognostic significance of micrometastasis and HPV DNA presence in lymph nodes, contributing valuable insights into long-term patient outcomes.

Aliases

Anna Germanová is also known by several aliases, including A Germanova, A Germanová, and Anna Germanova.

Publication and Citation Metrics

Citation Count	460
H-index	13
Paper Count	36

Publications:

Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX.

DOI: 10.1016/j.ygyno.2020.12.018

Year: 2021

606 Prognostic significance of HPV DNA presence in lymph nodes in cervical cancer patients – a long term follow-up

DOI: 10.1136/ijgc-2021-esgo.49

Year: 2021

Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery

DOI: 10.1038/s41416-020-01204-w

Year: 2020

Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study

DOI: 10.3390/cancers12061438

Year: 2020

Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer

DOI: 10.1136/ijgc-2019-001113

Year: 2020

Central Pathology Review in SENTIX, a Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)

DOI: 10.3390/cancers12051115

Year: 2020

P26 Micrometastasis in sentinel lymph nodes is a significant negative prognostic marker in early-stage cervical cancer

DOI: 10.1136/ijgc-2019-ESGO.89

Year: 2019

Diagnostic performance of ultrasound in the assessment of parametrial involvement before surgery in cervical cancer patients (diagnostic accuracy study)

DOI: 10.1136/ijgc-2019-esgo.22

Year: 2019

P36 SENTIX – a prospective cohort international study on sentinel lymph node biopsy without pelvic lymph node dissection in cervical cancer patients: central quality control of SLN pathological assessment (CEEGOG-CX01; ENGOT-CX2; NCT02494063)

DOI: 10.1136/ijgc-2019-esgo.99

Year: 2019

Oncological outcome of surgical management in patients with recurrent uterine cancer—a multicenter retrospective cohort study—CEEGOG EX01 Trial

DOI: 10.1136/ijgc-2019-000292

Year: 2019

How Can Water Poisoning be Prevented?

How can kidney disorders be managed in the context of gynecology?

How can healthcare providers address the emotional needs of gynecological patients?

How Can Women Improve Bone Health?

How is Fetal Distress Diagnosed?

How are Hormonal Tests Performed?

What role does confidentiality play in gynecology?

What types of drug information are available?

What is Proper Placement in Gynecology?

Who Should Perform the Procedure?

Partnered Content Networks

Relevant Topics